Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia

Saved in:
Bibliographic Details
Main Authors: Fürstenau, Moritz (Author) , Bahlo, J. (Author) , Fink, A. M. (Author) , Lange, E. (Author) , Dreger, Peter (Author) , Dreyling, M. (Author) , Hess, G. (Author) , Ritgen, M. (Author) , Kneba, M. (Author) , Döhner, H. (Author) , Stilgenbauer, S. (Author) , Wendtner, C. M. (Author) , Goede, V. (Author) , Fischer, K. (Author) , Böttcher, S. (Author) , Hallek, M. (Author) , Eichhorst, B. (Author)
Format: Article (Journal)
Language:English
Published: [2020]
In: Leukemia
Year: 2019, Volume: 34, Issue: 3, Pages: 924-928
ISSN:1476-5551
DOI:10.1038/s41375-019-0597-3
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41375-019-0597-3
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41375-019-0597-3
Get full text
Author Notes:M. Fürstenau, J. Bahlo, A.M. Fink, E. Lange, P. Dreger, M. Dreyling, G. Hess, M. Ritgen, M. Kneba, H. Döhner, S. Stilgenbauer, C.M. Wendtner, V. Goede, K. Fischer, S. Böttcher, M. Hallek, B. Eichhorst
Description
Item Description:Published online: 14 October 2019
Gesehen am 16.04.2020
Physical Description:Online Resource
ISSN:1476-5551
DOI:10.1038/s41375-019-0597-3